December 11, 2009 (FinancialWire) — Kensey Nash Corp.’s (NASDAQ: KNSY) said its board of directors has approved a stock repurchase. The new program allows the company to repurchase up to a total of 400,000 of its issued and outstanding shares of common stock and has no scheduled expiration.

The company said it intends to finance the repurchases using its available cash. As of November 30, 2009, the company had approximately 11,008,568 shares of common stock outstanding.

Pennsylvania-based Kensey Nash is engaged in developing, manufacturing and processing resorbable biomaterial products, incorporating its proprietary collagen and synthetic polymer technology.

The company has a range of products, which are sold in multiple medical markets, including, the cardiology, orthopedic, sports medicine, spine, endovascular and general surgery markets.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.